Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.

BMJ (Clinical research ed.)

Volumn 340, Issue , 2010, Pages

  Renoux, Christel ^a   Dell'aniello, Sophie ^b   Garbe, Edeltraut ^b   Suissa, Samy ^b  

^a MCGILL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

AGED; ARTICLE; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; RISK FACTOR; STROKE;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; AGED; CASE-CONTROL STUDIES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROGESTINS; RISK FACTORS; STROKE;

EID: 79953120230     PISSN: None     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.c2519     Document Type: Article

References (0)